JP2006333844A - Compounding agent for fodder - Google Patents
Compounding agent for fodder Download PDFInfo
- Publication number
- JP2006333844A JP2006333844A JP2005165657A JP2005165657A JP2006333844A JP 2006333844 A JP2006333844 A JP 2006333844A JP 2005165657 A JP2005165657 A JP 2005165657A JP 2005165657 A JP2005165657 A JP 2005165657A JP 2006333844 A JP2006333844 A JP 2006333844A
- Authority
- JP
- Japan
- Prior art keywords
- feed
- fodder
- mannose
- animals
- compounding agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000013329 compounding Methods 0.000 title abstract description 10
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract description 21
- 241001465754 Metazoa Species 0.000 claims abstract description 17
- 210000004027 cell Anatomy 0.000 claims abstract description 15
- 210000005253 yeast cell Anatomy 0.000 claims abstract description 10
- 229920000057 Mannan Polymers 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 28
- 238000009472 formulation Methods 0.000 claims description 23
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
- 244000005700 microbiome Species 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 13
- 235000014655 lactic acid Nutrition 0.000 claims description 7
- 239000004310 lactic acid Substances 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000007857 degradation product Substances 0.000 claims description 2
- 206010012735 Diarrhoea Diseases 0.000 abstract description 15
- 241000186660 Lactobacillus Species 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- 229920001542 oligosaccharide Polymers 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000000968 intestinal effect Effects 0.000 abstract description 3
- 229940039696 lactobacillus Drugs 0.000 abstract description 3
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 244000144972 livestock Species 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 241000209140 Triticum Species 0.000 description 8
- 235000021307 Triticum Nutrition 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 235000013312 flour Nutrition 0.000 description 8
- 244000309466 calf Species 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000194032 Enterococcus faecalis Species 0.000 description 4
- 241000194036 Lactococcus Species 0.000 description 4
- 239000003674 animal food additive Substances 0.000 description 4
- 229940032049 enterococcus faecalis Drugs 0.000 description 4
- 244000060011 Cocos nucifera Species 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- 241000194033 Enterococcus Species 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010057248 Cell death Diseases 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000028043 self proteolysis Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 241000193408 Bacillus badius Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000186148 Bifidobacterium pseudolongum Species 0.000 description 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 240000003173 Drymaria cordata Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 108010054377 Mannosidases Proteins 0.000 description 1
- 102000001696 Mannosidases Human genes 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 235000005733 Raphanus sativus var niger Nutrition 0.000 description 1
- 244000155437 Raphanus sativus var. niger Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 241000006364 Torula Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Fodder In General (AREA)
Abstract
Description
本発明は、動物飼料用の飼料配合剤に関するものである。 The present invention relates to a feed formulation for animal feed.
鶏、豚、羊、牛などの家畜は幼少期に大腸菌、あるいは、サルモネラ菌などの有害細菌や病原性ウィルスなどに感染すると下痢を起こすことが知られている。これらの家畜が下痢を起こすと、摂取した栄養を腸管から十分吸収することができずに成長が停滞するうえ、また、体力や抵抗力も低下して他の感染症にもかかりやすくなるという問題がある。また、養殖魚等の魚介類においても、細菌やウィルスなど病原性微生物に感染すれば成長が停滞し、斃死率が増加するという問題がある。 Livestock such as chickens, pigs, sheep and cows are known to cause diarrhea when infected with harmful bacteria such as Escherichia coli or Salmonella or pathogenic viruses during childhood. If these livestock cause diarrhea, they will not be able to absorb enough nutrients from the intestinal tract and growth will stagnate, and their physical strength and resistance will decrease, making it more susceptible to other infections. is there. In addition, fish and shellfish such as aquaculture fish also have a problem that if they are infected with pathogenic microorganisms such as bacteria and viruses, their growth stagnate and the death rate increases.
一方、近年の畜産業では、家畜の生産性を高めより高い経済効果を得るための工夫がなされてきた。たとえば、面積あたりの飼養頭数を多くすることによって生産性を高めようとしてきたが、逆に過密飼育によるストレスが家畜の体力や抵抗力を低下させ、生産性に悪影響を及ぼしていると言われている。さらに、過密飼育の畜舎内でひとたび感染症が発生すれば、それが畜舎内全体に蔓延し、さらに生産性を悪化させるという問題があった。これに対して家畜の病気予防と成長促進を目的として抗生物質や抗菌剤などの薬剤が飼料に混ぜて給与されるようになったが、耐性菌出現の問題、あるいは、薬剤漬けで生産された畜産物の安全性の問題が指摘されるようになり、抗生物質などの薬剤に代わる安全な資材が求められている。 On the other hand, in the recent livestock industry, efforts have been made to increase the productivity of livestock and obtain higher economic effects. For example, it has been attempted to increase productivity by increasing the number of captive animals per area, but conversely, stress due to overcrowded breeding is said to reduce the physical strength and resistance of livestock and adversely affect productivity. Yes. Furthermore, once an infection occurs in an overcrowded barn, it spreads throughout the barn and further deteriorates productivity. On the other hand, antibiotics and antibacterial drugs have been mixed with feed for the purpose of preventing disease and promoting growth in livestock. The problem of the safety of livestock products has been pointed out, and there is a demand for safe materials to replace antibiotics and other drugs.
このような要望に応えるものとして天然物に由来する添加物などが提案されている。具体的には、枸杞葉、麦芽、枇杷葉、人参、大棗、山薬、黄精、金銀花、蒲公英、または、ハコベを構成成分とする豚の肉質向上と生育促進用飼料が知られている(例えば、特許文献1参照)。また、シュガー系フレーバーと甘草、ステビア抽出物からなる嗜好性向上と下痢軽減を目的とした家畜用飼料添加剤が知られている(例えば、特許文献2参照)。さらに、9種類のハーブ類、酵母、乳酸菌、および有機酸を含有する豚用飼料添加剤が知られている(例えば、特許文献3参照)。あるいは、ハーブと酵母細胞壁、生菌剤、有機酸からなる動物用飼料添加剤が知られている(例えば、特許文献4参照)。
しかしながら、従来の技術では効果が十分に発揮されるには至っていなかった。 However, the conventional technique has not been fully effective.
本発明は、天然物由来の安全な成分で構成され、より効果的に動物の下痢を予防するとともに、より効果的に腸内環境を整えて動物の健康状態を向上させ、さらに成長を促進するための飼料配合剤及びそれを配合した飼料を提供することを目的とするものである。 The present invention is composed of safe ingredients derived from natural products, and more effectively prevents animal diarrhea, improves the intestinal environment more effectively, improves animal health, and further promotes growth. It aims at providing the feed compounding agent for this and the feed which mix | blended it.
本発明者らは、このような課題を解決するために、鋭意検討した結果、マンノースまたはマンノオリゴ糖あるいはそれらの両方と、微生物の死菌体を配合した飼料を動物に与えることによって、下痢が防止されるとともに健康状態が相乗的に向上し、さらにこれらの飼料を家畜に与えた場合には、家畜の生産性が向上することを見出し、本発明に至った。 As a result of diligent studies to solve such problems, the present inventors have prevented diarrhea by providing animals with a diet containing mannose and / or mannooligosaccharides, or both, and dead cells of microorganisms. In addition, the present inventors have found that when the health condition is synergistically improved, and when these feeds are given to livestock, the productivity of livestock is improved and the present invention has been achieved.
すなわち、本発明の第一は、マンノース及び/又はマンノオリゴ糖と、微生物の死菌体とを有効成分とすることを特徴とする飼料配合剤を要旨とするものであり、好ましくは、マンノース及び/又はマンノオリゴ糖が、マンナン分解物であるものであり、また、好ましくは、微生物の死菌体が、酵母細胞破砕物又は乳酸菌死菌体であるものである。 That is, the first of the present invention is a feed formulation characterized by comprising mannose and / or mannooligosaccharide and dead microorganisms of microorganisms as active ingredients, preferably mannose and / or Alternatively, the manno-oligosaccharide is a mannan degradation product, and preferably, the dead cell of the microorganism is a yeast cell disrupted product or a lactic acid bacteria killed cell.
また、本発明の第二は、前記した飼料配合剤を配合したことを特徴とする動物用飼料を要旨とするものである。 The second aspect of the present invention is an animal feed characterized by blending the above-mentioned feed compounding agent.
本発明によれば、天然物由来の安全な成分が、より効果的に動物の下痢を予防し、さらに成長を促進するなどの効果を十分に発揮することができ、特に仔牛、子豚、幼雛などの幼少期の家畜・家禽に適用した場合に有効である。 According to the present invention, a safe ingredient derived from a natural product can sufficiently exhibit effects such as preventing diarrhea in animals and promoting growth more effectively. It is effective when applied to young livestock and poultry such as chicks.
以下、本発明を詳細に説明する。まず、本発明に用いられるマンノース及びマンノオリゴ糖について説明する。マンノース及びマンノオリゴ糖は、天然由来のマンナン含有物を酸あるいは酵素によって加水分解することによって得られるものであり、精製物であっても粗精製物であっても構わない。天然由来のマンナン含有物としては、例えば、グアガム、ローカスビーンガム、パーム核、コプラミールなどの植物由来の多糖類のほか、酵母細胞壁などの微生物由来の多糖類などが使用できる。これらのマンナン含有物から酵素処理によってマンノース及びマンノオリゴ糖を得るには、マンナナーゼ、マンノシダーゼ、グルコシダーゼ、ガラクトシダーゼ、ヘミセルラーゼなどの酵素を作用させる公知の方法を用いればよい。 The present invention will be described in detail below. First, mannose and mannooligosaccharide used in the present invention will be described. Mannose and mannooligosaccharide are obtained by hydrolyzing a naturally-occurring mannan-containing product with an acid or an enzyme, and may be a purified product or a crude product. Examples of naturally-occurring mannan-containing products include polysaccharides derived from microorganisms such as yeast cell walls, as well as plant-derived polysaccharides such as guar gum, locust bean gum, palm kernel, and copra meal. In order to obtain mannose and mannooligosaccharides from these mannan-containing materials by enzymatic treatment, a known method in which an enzyme such as mannanase, mannosidase, glucosidase, galactosidase, hemicellulase or the like is used may be used.
一方、本発明で用いられる微生物の死菌体とは、動物に対して有害性を示さない細菌、酵母等の微生物を滅菌、殺菌、破砕、自己消化、酵素分解等の方法によって死滅させたものであり、酵母細胞破砕物や乳酸菌死菌体などを使用することができる。一例として、酵母の場合は、アルコールの醸造、パンの製造などに用いられる酵母(Saccromyces cerevisiae)、あるいはトルラ酵母(Candida utilis)等の酵母を自己消化、酵素処理、超音波処理、圧力などの手段によって細胞を破砕した酵母細胞破砕物を使用することができる。また、乳酸菌死菌体とは、乳酸球菌(エンテロコッカス属)、あるいは、乳酸桿菌(ラクトバシラス属)などの菌体を加熱等の方法により殺菌したものが使用できる。これらの死菌体は家畜の腸管免疫系を刺激して免疫を賦活させて動物の抗病性を高めることが知られている。 On the other hand, dead cells of microorganisms used in the present invention are those obtained by killing microorganisms such as bacteria and yeasts that are not harmful to animals by methods such as sterilization, sterilization, crushing, autolysis, and enzymatic degradation. It is possible to use a yeast cell disruption product or a lactic acid bacteria killed cell body. As an example, in the case of yeast, yeast (Saccromyces cerevisiae) used for alcoholic brewing, bread production, or yeast such as Torula yeast (Candida utilis), such as autolysis, enzyme treatment, ultrasonic treatment, pressure, etc. The yeast cell disruption material which disrupted the cell by can be used. In addition, lactic acid bacteria killed cells may be those obtained by sterilizing cells such as lactic acid cocci (genus Enterococcus) or lactobacilli (genus Lactobacillus) by a method such as heating. These dead cells are known to stimulate the intestinal immunity system of domestic animals to activate immunity and increase the anti-disease properties of animals.
本発明の飼料配合剤は、上記の成分を所定量混合することで得られるものである。混合する方法としては、どのような混合方法を採用してもよい。 The feed formulation of the present invention is obtained by mixing a predetermined amount of the above components. Any mixing method may be adopted as a mixing method.
本発明の飼料配合剤1g中に含まれるマンノース及び/又はマンノオリゴ糖と、微生物の死菌体の含有量としては、マンノース及び/又はマンノオリゴ糖は、0.001〜0.9gが好ましく、0.02〜0.8gがさらに好ましく、0.05〜0.5gが最も好ましい。微生物の死菌体は、0.05〜0.99gが好ましく、0.08〜0.9gがさらに好ましく、0.1〜0.5が最も好ましい。 As content of the mannose and / or mannooligosaccharide contained in 1g of feed compounding agents of this invention, and the dead cell body of microorganisms, 0.001-0.9g is preferable, and mannose and / or mannooligosaccharide is 0.00. 02 to 0.8 g is more preferable, and 0.05 to 0.5 g is most preferable. The dead cell of the microorganism is preferably 0.05 to 0.99 g, more preferably 0.08 to 0.9 g, and most preferably 0.1 to 0.5.
また、本発明の飼料添加剤には、マンノースあるいはマンノオリゴ糖による整腸作用を助ける目的で、オリゴ糖、発酵性有機酸、水溶性食物繊維、デンプン、不溶性食物繊維などのプレバイオティクスや、生菌剤などのプロバイオティクスを添加してもよい。 In addition, the feed additive of the present invention includes prebiotics such as oligosaccharides, fermentable organic acids, water-soluble dietary fibers, starches, and insoluble dietary fibers for the purpose of assisting intestinal regulation by mannose or mannooligosaccharides. Probiotics such as fungi may be added.
生菌剤としては、ラクトバチルス アシドフィルス、ラクトバチルス サリバリウス、ラクトバチルス カゼイなどのラクトバチルス(Lactobacillus)属、ビフィドバクテリウム サーモフィラム、ビフィドバクテリウム シュードロンガム、ビフィドバクテリウム ロンガムなど一般にビフィズス菌といわれているビフィドバクテリウム(Bifidobacterium)属、エンテロコッカス フェーカリス、エンテロコッカス フェシウムなどのエンテロコッカス(Enterococcus)属、ストレプトコッカス サーモフィルス、ストレプトコッカス ミュータンスどのストレプトコッカス(Streptococcus)属、ペディオコッカス(Pediococcus)属、ロイコノストック(Leuconostoc)属、ラクトコッカス(Lactococcus)など、一般に乳酸菌といわれる生菌、あるいは、クロストリジウム ブチリカムなどの酪酸菌(Clostridium属)、バチルス サブチルス(枯草菌)、バチルス セレウス、バチルス バディウス、バチルス コアグランスなどのバチルス(Bacillus)属などが家畜用飼料として一般に用いられている。 Examples of viable bacteria include Lactobacillus genus such as Lactobacillus acidophilus, Lactobacillus salivarius, Lactobacillus casei, Bifidobacterium thermophilum, Bifidobacterium pseudolongum, Bifidobacterium longum, etc. Bifidobacterium genus, Enterococcus faecalis, Enterococcus genus Enterococcus, Streptococcus thermophilus, Streptococcus mutans Streptococcus genus, Pediococcus genus (Leuconostoc) genus, Lactococcus, etc., live bacteria generally called lactic acid bacteria, or Clostridium Butyric acid bacteria such as Chirikamu (Clostridium genus), Bacillus subtilis (B. subtilis), Bacillus cereus, Bacillus badius, such as Bacillus (Bacillus) genus, such as Bacillus coagulans are commonly used as livestock feed.
さらに、必要に応じて、安定剤や賦形剤が含まれても構わない。安定剤としては、無水ケイ酸などが挙げられ、賦形剤としては、ふすま、小麦粉、コーンスターチ、コーングルテンフィード、デキストリン、米糠などが挙げられる。 Furthermore, a stabilizer and an excipient may be included as necessary. Examples of the stabilizer include silicic acid anhydride, and examples of the excipient include bran, wheat flour, corn starch, corn gluten feed, dextrin, rice bran and the like.
本発明の第二の動物用飼料は、上記した飼料配合剤を配合したものである。配合割合は、0.005〜5質量%が好ましく、0.02〜2質量%がさらに好ましく、0.1〜2重量%が最も好ましい。 The 2nd animal feed of this invention mix | blends the above-mentioned feed compounding agent. The blending ratio is preferably 0.005 to 5% by weight, more preferably 0.02 to 2% by weight, and most preferably 0.1 to 2% by weight.
以下、実施例により本発明を具体的に説明する。なお、本発明は実施例に限定されるものではない。 Hereinafter, the present invention will be described specifically by way of examples. In addition, this invention is not limited to an Example.
実施例1
酵素処理コプラミール由来マンノース(商品名「コッコエース」、ユニチカ株式会社製)0.4gと、飼料用酵素処理酵母(商品名「ニュートリセルモス」)0.4gと、小麦粉0.2gを混合し、本発明の飼料配合剤を作製した。
Example 1
Enzyme-treated copra meal-derived mannose (trade name “Kocco Ace”, manufactured by Unitika Ltd.) 0.4 g, feed enzyme-treated yeast (trade name “Nutricermos”) 0.4 g, and wheat flour 0.2 g are mixed, The feed formulation of the present invention was prepared.
実施例2
酵素処理コプラミール由来マンノース(商品名「コッコエース」、ユニチカ株式会社製)0.4gと、乳酸球菌(エンテロコッカ スフェカリス)死菌0.4gと、小麦粉0.2gを混合し、本発明の飼料配合剤を作製した。
Example 2
Enzyme-treated copra meal-derived mannose (trade name “Kocco Ace”, manufactured by Unitika Ltd.) 0.4 g, lactococcus (enterococcus faecalis) killed bacteria 0.4 g, and wheat flour 0.2 g are mixed, and the feed composition of the present invention An agent was prepared.
実施例3
酵母細胞由来マンノース(商品名「バイオモス」、オルテック社製)0.4gと、飼料用酵素処理酵母(商品名「ニュートリセルモス」)0.4gと、小麦粉0.2gを混合し、本発明の飼料配合剤を作製した。
Example 3
Yeast cell-derived mannose (trade name “Biomos”, manufactured by Oltech) 0.4 g, feed enzyme-treated yeast (trade name “Nutricermos”) 0.4 g, and wheat flour 0.2 g are mixed. A feed formulation was prepared.
実施例4
酵母細胞由来マンノース(商品名「バイオモス」、オルテック社製)0.4gと、乳酸球菌(エンテロコッカ スフェカリス)死菌0.4gと、小麦粉0.2gを混合し、本発明の飼料配合剤を作製した。
Example 4
Yeast cell-derived mannose (trade name “Biomos”, manufactured by Oltech) 0.4 g, Lactococcus (Enterococcus faecalis) killed 0.4 g, and wheat flour 0.2 g are mixed to produce the feed formulation of the present invention. did.
比較例1
酵母細胞由来マンノース(商品名「バイオモス」、オルテック社製)0.4gと、小麦粉0.6gを混合し飼料配合剤を作製した。
Comparative Example 1
Yeast cell-derived mannose (trade name “Biomos”, manufactured by Oltech) 0.4 g and wheat flour 0.6 g were mixed to prepare a feed formulation.
比較例2
飼料用酵素処理酵母(商品名「ニュートリセルモス」)0.4gと、小麦粉0.6gを混合し飼料配合剤を作製した。
Comparative Example 2
A feed compounding agent was prepared by mixing 0.4 g of feed enzyme-treated yeast (trade name “Nutricermos”) and 0.6 g of wheat flour.
比較例3
乳酸球菌(エンテロコッカ スフェカリス)死菌0.4gと、小麦粉0.6gを混合し飼料配合剤を作製した。
Comparative Example 3
A feed formulation was prepared by mixing 0.4 g of killed Lactococcus (Enterococcus faecalis) and 0.6 g of wheat flour.
試験例1
実施例1〜4、比較例1〜3で作製した飼料配合剤を市販の子豚用人工乳に添加し配合飼料を作製した。飼料配合剤の添加率は0.3%とし、子豚用人工乳は子豚の生育ステージに応じて変更した。1群30頭の子豚に作製した飼料を給与して5日齢から70日齢まで飼育した。また比較として、飼料配合剤を添加せずに市販の子豚用人工乳のみを給与して同様に飼育した(比較例4)。
Test example 1
The feed composition prepared in Examples 1 to 4 and Comparative Examples 1 to 3 was added to commercially available artificial milk for piglets to prepare a blended feed. The feed compounding rate was 0.3%, and the artificial milk for piglets was changed according to the growth stage of the piglets. A group of 30 piglets were fed the prepared feed and reared from 5 to 70 days of age. Moreover, as a comparison, only commercially available artificial milk for piglets was fed without adding the feed formulation, and the animals were reared in the same manner (Comparative Example 4).
飼育した豚の飼育期間中の5日齢から40日齢までの糞便状態を観察し、平均下痢日数を表1に示した。 The stool state from 5 days to 40 days of age during the breeding period of the domestic pigs was observed.
また、上記試験例1で飼育した子豚の飼育期間中の健康状態を目視観察した結果を表2に示した。 Table 2 shows the results of visual observation of the health condition of the piglets raised in Test Example 1 during the breeding period.
さらに、上記試験例1で飼育した豚の飼育期間中のうち出生時、21日齢、70日齢の平均体重を比較した結果を表3に示した。 Furthermore, Table 3 shows the results of comparing the average body weights of the pigs raised in Test Example 1 at the time of birth, 21 days of age, and 70 days of age.
試験例2
実施例1、3および、比較例1,3で作製した飼料配合剤を市販の仔牛用人工乳に添加し飼料を作製した。飼料配合剤の添加率は0.2%とし、飼料は仔牛の生育ステージに応じて変更した。1群3頭の肉牛仔牛に作製した飼料を給与し、1ヶ月齢から3ヶ月齢まで飼育した。また、比較として飼料配合剤を添加せずに市販の人工乳のみを給与して同様に飼育した(比較例5)。
Test example 2
The feed formulation prepared in Examples 1 and 3 and Comparative Examples 1 and 3 was added to commercially available calf artificial milk to prepare a feed. The addition rate of the feed formulation was 0.2%, and the feed was changed according to the growth stage of the calf. A group of three beef calves was fed with the prepared feed and raised from 1 month to 3 months of age. In addition, as a comparison, only commercially available artificial milk was fed without adding the feed formulation, and reared in the same manner (Comparative Example 5).
上記、試験例2で飼育した仔牛の試験期間中の糞便状態を毎日観察し、糞便スコアを記録した。糞便スコアは、正常便:0ポイント、軟便:1ポイント、下痢便:2ポイント、水様便:3ポイントとした。表3に観察期間中に平均下痢日数と糞便スコア平均値を表4に示した。 The stool state of the calves bred in Test Example 2 was observed every day during the test period, and the stool score was recorded. The fecal score was 0 points for normal stool, 1 point for soft stool, 2 points for diarrhea, and 3 points for watery stool. Table 3 shows the average diarrhea days and the average stool score during the observation period.
上記の結果、本発明の飼料配合剤を家畜に給与することによって、より効果的に家畜の下痢予防と健康状態の向上、さらに成長促進を相乗的に高めることが分かった。
As a result, it was found that feeding the livestock formulation of the present invention to livestock synergistically enhances the prevention of livestock diarrhea, the improvement of health, and the promotion of growth.
Claims (4)
An animal feed comprising the feed formulation according to any one of claims 1 to 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005165657A JP2006333844A (en) | 2005-06-06 | 2005-06-06 | Compounding agent for fodder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005165657A JP2006333844A (en) | 2005-06-06 | 2005-06-06 | Compounding agent for fodder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2006333844A true JP2006333844A (en) | 2006-12-14 |
Family
ID=37554925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005165657A Pending JP2006333844A (en) | 2005-06-06 | 2005-06-06 | Compounding agent for fodder |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2006333844A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010529980A (en) * | 2007-06-13 | 2010-09-02 | グリコス フィンランド オイ | Nutritional composition |
| JP2015189738A (en) * | 2014-03-28 | 2015-11-02 | 味の素ゼネラルフーヅ株式会社 | Skin quality improver |
| JP2022153806A (en) * | 2021-03-30 | 2022-10-13 | ミツハナ株式会社 | Feed additive with red mites repelling effect |
-
2005
- 2005-06-06 JP JP2005165657A patent/JP2006333844A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010529980A (en) * | 2007-06-13 | 2010-09-02 | グリコス フィンランド オイ | Nutritional composition |
| JP2015189738A (en) * | 2014-03-28 | 2015-11-02 | 味の素ゼネラルフーヅ株式会社 | Skin quality improver |
| JP2022153806A (en) * | 2021-03-30 | 2022-10-13 | ミツハナ株式会社 | Feed additive with red mites repelling effect |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2902034T3 (en) | Yeast-bacterial probiotic combinations and methods of use to improve pig production | |
| CN104758318B (en) | A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate | |
| US20210329944A1 (en) | Bacillus subtilis for animal feed | |
| CN105475624A (en) | Microbial fermentation feed as well as production method and application thereof | |
| JP2017533197A (en) | Probiotic composition and prebiotic composition | |
| CN103271244A (en) | Preparation method of pig feed zymophyte additive | |
| CN109475151A (en) | Immunomodulatory and growth-promoting compositions for controlling harmful bacteria in the gut microbiota and uses thereof | |
| JP6596135B2 (en) | Composition for improving intestinal environment, inhibiting weight gain by ingesting a high-fat diet, or inhibiting H. pylori | |
| KR101168658B1 (en) | Probiotics and fermenting livestock feed with probiotics and by-product of agricultual product | |
| Patience et al. | Invited review: strategic adoption of antibiotic-free pork production: the importance of a holistic approach | |
| Radzikowski et al. | Selected feed additives used in pig nutrition | |
| JP2006333842A (en) | Compounding agent for fodder | |
| CN112689459A (en) | Improved animal feed products | |
| JP5499231B2 (en) | Animal feed composition containing Lactobacillus plantarum, combined animal feed containing the composition, and method for maintaining or growing the Lactobacillus plantarum in the animal intestine | |
| JP2021516258A (en) | Use of direct feeding microorganisms in the prevention and / or treatment of E. coli-based infections in animals | |
| JP2002262779A (en) | Sorbic acid material as feed additive for raising agricultural livestock | |
| JP2016079118A (en) | Immunomodulator, health supplement feed, and feed | |
| Jatkauskas et al. | Effects of encapsulated probiotic Enterococcus faecium strain on diarrhoea patterns and performance of early weaned calves. | |
| US20220322702A1 (en) | Seaweed blend feed supplement | |
| US20180084803A1 (en) | Probiotic nutritional supplement for animals | |
| Natsir et al. | Effect of either non-encapsulated or encapsulated acidifier-phytobiotic-probiotic on performance, intestinal characteristics and intestinal microflora of local hybrid ducks | |
| RU2652835C1 (en) | Method of productivity increasing and offspring preservation in pig breeding (options) | |
| Weiss et al. | Combinations of feed additives affect ileal fibre digestibility and bacterial numbers in ileal digesta of piglets. | |
| US20180279647A1 (en) | Composition for animal feed enhancement | |
| JP2006333845A (en) | Compounding agent for fodder |